- Home
- LGO vs GNTA Comparison
LGO vs GNTA Comparison
Compare LGO & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGO | GNTA |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | Canada | Italy |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.8M | 62.7M |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LGO | GNTA |
|---|---|---|
| Price | $0.68 | $0.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.25 | N/A |
| AVG Volume (30 Days) | ★ 534.7K | 37.6K |
| Earning Date | 05-12-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $50.56 | N/A |
| Revenue Next Year | $59.94 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.55 |
| 52 Week High | $2.70 | $10.00 |
Technical Indicators
Market Signals| Indicator | LGO | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 26.89 |
| Support Level | $0.61 | $0.58 |
| Resistance Level | $0.83 | $0.91 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 13.12 | 3.00 |
Price Performance
Historical ComparisonAbout LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.